Acorah Software Products - Accounts Production 16.5.460 false true 31 January 2024 1 February 2023 false 1 February 2024 31 January 2025 31 January 2025 08847030 Mr SHANMUGA NATARAJAN Dr Shanmuga Natarajan true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08847030 2024-01-31 08847030 2025-01-31 08847030 2024-02-01 2025-01-31 08847030 frs-core:CurrentFinancialInstruments 2025-01-31 08847030 frs-core:Non-currentFinancialInstruments 2025-01-31 08847030 frs-core:BetweenOneFiveYears 2025-01-31 08847030 frs-core:ComputerEquipment 2025-01-31 08847030 frs-core:ComputerEquipment 2024-02-01 2025-01-31 08847030 frs-core:ComputerEquipment 2024-01-31 08847030 frs-core:MotorVehicles 2025-01-31 08847030 frs-core:MotorVehicles 2024-02-01 2025-01-31 08847030 frs-core:MotorVehicles 2024-01-31 08847030 frs-core:ShareCapital 2025-01-31 08847030 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31 08847030 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 08847030 frs-bus:FilletedAccounts 2024-02-01 2025-01-31 08847030 frs-bus:SmallEntities 2024-02-01 2025-01-31 08847030 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 08847030 frs-bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 08847030 1 2024-02-01 2025-01-31 08847030 frs-bus:Director1 2024-02-01 2025-01-31 08847030 frs-countries:EnglandWales 2024-02-01 2025-01-31 08847030 2023-01-31 08847030 2024-01-31 08847030 2023-02-01 2024-01-31 08847030 frs-core:CurrentFinancialInstruments 2024-01-31 08847030 frs-core:Non-currentFinancialInstruments 2024-01-31 08847030 frs-core:BetweenOneFiveYears 2024-01-31 08847030 frs-core:ShareCapital 2024-01-31 08847030 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31
Registered number: 08847030
VIJAY MEDICAL CONSULTING LTD
Financial Statements
For The Year Ended 31 January 2025
TOCKAN & CO
CHARTERED CERTIFIED ACCOUNTANTS
289 Brettenham Road
Edmonton
London
N18 2HF
VIJAY MEDICAL CONSULTING LTD
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—4

Page 1
VIJAY MEDICAL CONSULTING LTD
Balance Sheet
As At 31 January 2025
Balance Sheet
Registered number: 08847030

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 28,567 |  | 38,023
|  |  | 28,567 |  | 38,023
CURRENT ASSETS
Cash at bank and in hand |  | 349,928 |  | 337,322 |
|  | 349,928 |  | 337,322 |
Creditors: Amounts Falling Due Within One Year | 6 | (44,994 ) |  | (40,572 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 304,934 |  | 296,750
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 333,501 |  | 334,773
Creditors: Amounts Falling Due After More Than One Year | 7 |  | (4,107 ) |  | (13,161 )
NET ASSETS |  |  | 329,394 |  | 321,612
CAPITAL AND RESERVES
Called up share capital | 9 |  | 2 |  | 2
Profit and Loss Account |  |  | 329,392 |  | 321,610
SHAREHOLDERS' FUNDS |  |  | 329,394 |  | 321,612

Page 1
Page 2
VIJAY MEDICAL CONSULTING LTD
Balance Sheet (continued)
As At 31 January 2025
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr SHANMUGA NATARAJAN Director
08/10/2025

The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
VIJAY MEDICAL CONSULTING LTD
Notes to the Financial Statements
For The Year Ended 31 January 2025
Notes to the Financial Statements
1. General Information
VIJAY MEDICAL CONSULTING LTD Registered number 08847030 is a limited by shares company incorporated in England & Wales. The Registered Office is 289 BRRETTENHAM ROAD, EDMONTON, LONDON, N18 2HF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).
2.2. Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Motor Vehicles | 25%
Computer Equipment | 25%

2.4. Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the profit and loss account as incurred.
2.5. Taxation
The charge for taxation takes into account taxation deferred as a result of timing differences between the treatment of certain items for taxation and accounting purposes. In general, deferred taxation is recognised in respect of timing differences that have originated but not reversed at the balance sheet date. However, deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted. Deferred taxation is measured on a non-discounted basis at the tax rates that are expected to apply in periods in which the timing differences reverse, based on tax rates and the law enacted or substantively enacted at the balance sheet date.
2.6. Registrar Filing Requirements
The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets

| Motor Vehicles | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 February 2024 | 59,300 | 10,972 | 70,272
As at 31 January 2025 | 59,300 | 10,972 | 70,272

...CONTINUED
Page 3
Page 4
VIJAY MEDICAL CONSULTING LTD
Notes to the Financial Statements (continued)
For The Year Ended 31 January 2025

Depreciation
As at 1 February 2024 | 25,944 | 6,305 | 32,249
Provided during the period | 8,339 | 1,117 | 9,456
As at 31 January 2025 | 34,283 | 7,422 | 41,705
Net Book Value
As at 31 January 2025 | 25,017 | 3,550 | 28,567
As at 1 February 2024 | 33,356 | 4,667 | 38,023

5. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year

6. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | (1 ) |  | -
Corporation tax | 37,159 |  | 34,943
Accruals & deferred income (Current liabilities - creditors < 1 year) | 5,550 |  | 5,000
Director's loan account | 2,286 |  | 629
| 44,994 |  | 40,572

7. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Net obligations under finance lease and hire purchase contracts | 4,107 |  | 13,161

8. Obligations Under Finance Leases and Hire Purchase

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
The future minimum finance lease payments are as follows:
Later than one year and not later than five years | 4,107 |  | 13,161

9. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 2 |  | 2

10. Dividends

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
On equity shares:
Final dividend paid | 100,000 |  | 100,000

11. Ultimate Controlling Party
The company's ultimate controlling party is Dr Shanmuga Natarajan by virtue of his ownership of 100% of the issued share capital in the company.
Page 4